International Chronic Myeloid Leukemia Pediatric Study

NCT01281735 · tracked via the Priya Life Science China tracker

Sponsor

Poitiers University Hospital

Phase

Observational

Started

2011-01

Last updated

2024-01-17

Condition(s) studied

Chronic Myeloid Leukemia

Study summary

The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.

Eligibility

Sex

ALL

Min age

—

Max age

18 Years

Healthy volunteers

Inclusion Criteria: * patients less than 18 years of age * diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases Exclusion Criteria: * patients more than 18 years of age at diagnosis of CML

Trial sites (20)

Facility	City	Region	Status
Women's and children's Hospital	North Adelaide	South Australia	Not Yet Recruiting
St. Anna Children's Cancer Research Institute and St. Anna Children's Hospital	Vienna	Austria	Recruiting
Belarussian Reseach Center for Pediatric Oncology and hematology (BRCPOH)	Minsk	Belarus	Recruiting
University Hospital of Ghent	Ghent	Belgium	Recruiting
Instituto de Oncologia Pediatrica	São Paulo	Brazil	Recruiting
Hospital Roberto Del Rio	Santiago	Chile	Not Yet Recruiting
Prince of Wales Hospital	Hong Kong	China	Recruiting
Children's Hospital Zagreb	Zagreb	Croatia	Recruiting
Charles University Motol	Prague	Czechia	Recruiting
Rigshospitalet	Copenhagen	Denmark	Recruiting
Clinical Investigation Center CIC 1402	Poitiers	France	Recruiting
University Hospital Dresden	Dresden	Germany	Recruiting
Agia Sophia Children's Hospital	Athens	Greece	Recruiting
Keio University School of Medicine	Tokyo	Japan	Not Yet Recruiting
Saint George Hospital University Medical Centre	Beirut	Lebanon	Recruiting
Dutch Childhood Oncology Group, Princess Maxima Center for pediatric oncology	Utrecht	Netherlands	Recruiting
Wroclaw Medical University Department	Wroclaw	Poland	Recruiting
University Children's Hospital	Bratislava	Slovakia	Recruiting
Officina Proyectos SEHOP	Palma de Mallorca	Spain	Recruiting
Uludag University, Medical Faculty	Görükle	Turkey (Türkiye)	Recruiting

Other trials for the same condition

TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients Recruiting

The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP Recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation Active, not recruiting

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01281735 on ClinicalTrials.gov ↗ ← All trials in China